Search research articles
Contact Us
Filters
Showing results (21-30 of 73) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1988
cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1
K W Johnson, B H Davis, K A Smith
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
February 9, 1999
Serotonin in migraine: theories, animal models and emerging therapies
K W Johnson, L A Phebus, M L Cohen
The Milbank Quarterly
|
January 1, 1987
Health differentials between blacks and whites: recent trends in mortality and morbidity
K G Manton, C H Patrick, K W Johnson
Journal of the American Pharmaceutical Association
|
September 1, 1977
Certificate of need and statement of social impact as requirements for new drug approvals
H R Manasse, J E Stewart, K W Johnson
Immunopharmacology
|
February 1, 1987
Primary cellular target responsible for dimethylnitrosamine-induced immunosuppression in the mouse
K W Johnson, A E Munson, M P Holsapple
AJR. American Journal of Roentgenology
|
December 1, 1980
Renal vein thrombosis in a child with the nephrotic syndrome: CT diagnosis
C C Coleman, K M Saxena, K W Johnson
Microbial Ecology
|
January 15, 2014
Southern Appalachian peatlands support high archaeal diversity
A N Hawkins, K W Johnson, S L Bräuer
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1986
An immunotoxicological evaluation of gamma-chlordane
K W Johnson, M P Holsapple, A E Munson
The Journal of Biological Chemistry
|
July 7, 1995
Ligand binding analysis of soluble interleukin-2 receptor complexes by surface plasmon resonance
Z Wu, K W Johnson, Y Choi, et al.
Cephalalgia : an International Journal of Headache
|
September 27, 2003
5-HT1F receptor agonists in acute migraine treatment: a hypothesis
N M Ramadan, V Skljarevski, L A Phebus, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 73) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1988
cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1
K W Johnson, B H Davis, K A Smith
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
February 9, 1999
Serotonin in migraine: theories, animal models and emerging therapies
K W Johnson, L A Phebus, M L Cohen
The Milbank Quarterly
|
January 1, 1987
Health differentials between blacks and whites: recent trends in mortality and morbidity
K G Manton, C H Patrick, K W Johnson
Journal of the American Pharmaceutical Association
|
September 1, 1977
Certificate of need and statement of social impact as requirements for new drug approvals
H R Manasse, J E Stewart, K W Johnson
Immunopharmacology
|
February 1, 1987
Primary cellular target responsible for dimethylnitrosamine-induced immunosuppression in the mouse
K W Johnson, A E Munson, M P Holsapple
AJR. American Journal of Roentgenology
|
December 1, 1980
Renal vein thrombosis in a child with the nephrotic syndrome: CT diagnosis
C C Coleman, K M Saxena, K W Johnson
Microbial Ecology
|
January 15, 2014
Southern Appalachian peatlands support high archaeal diversity
A N Hawkins, K W Johnson, S L Bräuer
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1986
An immunotoxicological evaluation of gamma-chlordane
K W Johnson, M P Holsapple, A E Munson
The Journal of Biological Chemistry
|
July 7, 1995
Ligand binding analysis of soluble interleukin-2 receptor complexes by surface plasmon resonance
Z Wu, K W Johnson, Y Choi, et al.
Cephalalgia : an International Journal of Headache
|
September 27, 2003
5-HT1F receptor agonists in acute migraine treatment: a hypothesis
N M Ramadan, V Skljarevski, L A Phebus, et al.
Page
of 8